Show simple item record

dc.contributor.advisorAtkins, Greg
dc.contributor.authorJerusalmi, Alan
dc.date.accessioned2019-07-25T13:21:30Z
dc.date.available2019-07-25T13:21:30Z
dc.date.issued2004
dc.identifier.citationAlan Jerusalmi, 'Development of the recombinant Semliki Forest virus vector as a gene therapy agent for the central nervous system', [thesis], Trinity College (Dublin, Ireland). School of Medicine. Discipline of Clinical Microbiology, 2004, pp 263
dc.identifier.otherTHESIS 7511
dc.identifier.urihttp://hdl.handle.net/2262/88895
dc.description.abstractMultiple sclerosis (MS) is a neurological disease of the central nervous system (CNS), and a major cause of disability in young adults. It is characterized by the presence of inflammatory infiltrates containing autoreactive T cells, resulting in demyelination and axonal loss within the CNS. One of the greatest challenges in the treatment of MS is to get the therapeutic agent to successfully cross the bloodrbrain barrier, and exert an activity inside the CNS.
dc.format1 volume
dc.language.isoen
dc.publisherTrinity College (Dublin, Ireland). School of Medicine. Discipline of Clinical Microbiology
dc.relation.isversionofhttp://stella.catalogue.tcd.ie/iii/encore/record/C__Rb12426471
dc.subjectMicrobiology, Ph.D.
dc.subjectPh.D. Trinity College Dublin
dc.titleDevelopment of the recombinant Semliki Forest virus vector as a gene therapy agent for the central nervous system
dc.typethesis
dc.type.supercollectionthesis_dissertations
dc.type.supercollectionrefereed_publications
dc.type.qualificationlevelDoctoral
dc.type.qualificationnameDoctor of Philosophy (Ph.D.)
dc.rights.ecaccessrightsopenAccess
dc.format.extentpaginationpp 263
dc.description.noteTARA (Trinity's Access to Research Archive) has a robust takedown policy. Please contact us if you have any concerns: rssadmin@tcd.ie


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record